Dear Reader,
In Dylan’s interview with Laycee from Marketbeat, he discussed the weight-loss drug craze, the “smart chemo” revolution and his system for picking biotech stocks in any market.
Dylan says…
My younger friends often tease me about my focus on the biotech sector. They say I should drop that and focus on “cool” things like crypto.
I smile and remind them that crypto may indeed be cool. But Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in January. Or to $200,000 to match the 300% gains on Viking Therapeutics in March.
I’m old school. Ain’t nothing cool about me, except money.
Here’s a link to the interview.
And here’s a link to our biotech calendar.
It’s like having x-ray vision into the biggest moves coming in biotech. We can predict the biggest trades weeks in advance.
To us, having a system battle-tested over 33 years, trading biotech through all kinds of markets…
A system that’s delivered average 64% gains on every trade since inception…
Has been a comfort in uncertain markets.
And speaking of markets – did you know biotech has been in a bear market even as the S&P 500 and Dow have raged to all-time highs?
Dylan has pulled these kinds of gains out of a bear market in biotech!
Imagine what he could do as biotech turns around.
But no matter what happens in the S&P, the Dow or in biotech…
Dylan relies on this calendar and his biotech system to pull gains out of the market with a 75% success rate and 64% average gains across all trades – wins and losses.
Go here to see the next 5 dates coming up >>>
“The Buck Stops Here”
P.S. The next big date on the calendar is set.
The stock scheduled to move that day is a tiny micro-cap that could soar 300%.
